ES2523682A1 - System for detecting commonly abused drugs - Google Patents

System for detecting commonly abused drugs Download PDF

Info

Publication number
ES2523682A1
ES2523682A1 ES201301178A ES201301178A ES2523682A1 ES 2523682 A1 ES2523682 A1 ES 2523682A1 ES 201301178 A ES201301178 A ES 201301178A ES 201301178 A ES201301178 A ES 201301178A ES 2523682 A1 ES2523682 A1 ES 2523682A1
Authority
ES
Spain
Prior art keywords
saliva
commonly abused
bands
positive
reactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201301178A
Other languages
Spanish (es)
Other versions
ES2523682B1 (en
Inventor
Valentín BALLESTEROS AGUADO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
V P Pharma Baru S L
Vp Pharma Baru Sl
Original Assignee
V P Pharma Baru S L
Vp Pharma Baru Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by V P Pharma Baru S L, Vp Pharma Baru Sl filed Critical V P Pharma Baru S L
Publication of ES2523682A1 publication Critical patent/ES2523682A1/en
Application granted granted Critical
Publication of ES2523682B1 publication Critical patent/ES2523682B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Abstract

The invention relates to a system that makes it possible to detect the presence of commonly abused substances in a saliva sample taken from the driver of a motor vehicle, with simultaneous identification of the commonly abused substance should the result be positive. The system is based on reactive strips that have a surface divided into a part for saliva absorption, a part for diagnosis and control with bands of reagent in order to determine a positive or negative result, and a part with bands of reactive material in order to identify the substance. The system is embodied by a kit that includes a tubular saliva collection chamber, having a circular or rectangular cross-section, a support with the reactive strips and a collecting cover having a support rod on the opposite end of which is a sponge to be moistened with the saliva of the test subject.

Description

imagen1image 1

imagen2image2

imagen3image3

imagen4image4

imagen5image5

imagen6image6

imagen7image7

imagen8image8

imagen9image9

imagen10image10

imagen11image11

imagen12image12

imagen13image13

imagen14image14

imagen15image15

imagen16image16

Claims (1)

imagen1image 1 imagen2image2
ES201301178A 2011-06-27 2011-06-27 Drug Abuse Detection System Expired - Fee Related ES2523682B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2011/000213 WO2013001102A1 (en) 2011-06-27 2011-06-27 System for detecting commonly abused drugs

Publications (2)

Publication Number Publication Date
ES2523682A1 true ES2523682A1 (en) 2014-11-28
ES2523682B1 ES2523682B1 (en) 2016-05-09

Family

ID=47423450

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201301178A Expired - Fee Related ES2523682B1 (en) 2011-06-27 2011-06-27 Drug Abuse Detection System

Country Status (2)

Country Link
ES (1) ES2523682B1 (en)
WO (1) WO2013001102A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19502375C2 (en) * 1995-01-26 2000-06-21 Denzel Klaus Narcotics detection system
US5874216A (en) * 1996-02-23 1999-02-23 Ensys Environmental Products, Inc. Indirect label assay device for detecting small molecules and method of use thereof
WO2000063697A1 (en) * 1997-11-05 2000-10-26 American Bio Medica Corporation Device for the testing of fluid samples and process for making the device
US8202487B2 (en) * 1998-07-22 2012-06-19 Jin Po Lee Multiple analyte assay devices
US6699722B2 (en) * 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
US6620626B1 (en) * 2000-08-09 2003-09-16 Mission Research Corp. Antigen detection device and method
US6989276B2 (en) * 2001-05-10 2006-01-24 Battelle Energy Alliance, Llc Rapid classification of biological components
GB2404023B (en) * 2004-07-02 2005-07-06 Cozart Bioscience Ltd Delta-9-tetrahydrocannabinol detection method
US8470609B2 (en) * 2007-09-11 2013-06-25 Jian Feng Chen Versatile drug testing device

Also Published As

Publication number Publication date
WO2013001102A1 (en) 2013-01-03
ES2523682B1 (en) 2016-05-09

Similar Documents

Publication Publication Date Title
EP3029153A3 (en) Mesothelioma biomarkers and uses thereof
BR112012005198A8 (en) Portable system, method for portablely collecting a sample of exhaled breath from an individual and using a system
EP2400306A3 (en) Sample analyzer and liquid aspirating method
HK1202925A1 (en) Test sensor for determining analyte concentration in fluid sample
IN2014CN01787A (en)
EP3578959A3 (en) Method for reading test strips
WO2009021131A3 (en) System and method for biological sample collection and analyte detection
JP2008522786A5 (en)
EP2450710A3 (en) Cancer biomarkers and methods of use thereof
JP2018524605A5 (en)
BRPI0909791A2 (en) Cartridge, sensing device and method for detecting target components in a liquid sample, and use of the sensing cartridge or device.
WO2010078465A3 (en) Capillary flow solid phase assay
EP3835753A3 (en) Systems and methods for detection of particles in a beneficial agent
EP3182122A3 (en) Chemical impairment detection system with an integrated, multi-function breath chamber
DE602006005927D1 (en) DEVICE FOR REMOVING, COLLECTING AND TRANSPORTING BIOLOGICAL SAMPLES
WO2011005893A3 (en) Biomarkers and methods for detecting alzheimer's disease
EP2631649A8 (en) Method and device for the rapid diagnosis of diseases in faecal samples
EP3159695A3 (en) Methods for diagnosing pancreatic cancer
JP2015522279A5 (en)
MX2010004335A (en) Method and system for detection of a selected type of molecules in a sample.
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
ATE495441T1 (en) METHOD FOR TESTING ENDOCRINE SUBSTANCES IN SAMPLES
ATE420358T1 (en) DEVICE ARRANGEMENT AND METHOD FOR DETECTING AN ANALYTE
JP2011518338A5 (en)
GB201017732D0 (en) Devices and methods for enrichment and alteration of circulating cells and other particles

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2523682

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20160509

FD2A Announcement of lapse in spain

Effective date: 20231026